Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

In some cases, "symptoms can escalate to more severe respiratory distress," infectious disease expert Dr. Tyler Evans told Newsweek.

announced neffy ® (epinephrine nasal spray) 1 mg is now available to patients and caregivers by prescription across the U.S. In March 2025, the U.S. Food and Drug Administration approved neffy ...

Carlos Alcaraz has been wearing nasal strips in some matches since last season. That's sparked an interest in the ...

The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal ...

A proposed classification system appears highly accurate in evaluating nasal deformities in infants with cleft lip and/or ...

The four-time Grand Slam champion, whose bid for a second consecutive French Open title was scheduled to continue with a ...